Final answer:
The dosing of Simponi (golimumab) for RA patients depends on various factors, including disease severity and patient response. The recommended starting dose is 50 mg once a month, but a higher dose of 100 mg may be used in severe cases. The dosing schedule can be adjusted based on the patient's condition.
Step-by-step explanation:
The dosing of Simponi (golimumab) for patients with rheumatoid arthritis (RA) may vary depending on several factors, including the severity of the disease, the patient's weight, and the patient's response to the medication. In general, the recommended starting dose is 50 mg once a month, given as a subcutaneous injection (under the skin). Some patients may benefit from a higher dose of 100 mg once a month, particularly those with more severe RA. The dosing schedule may be adjusted based on the patient's condition and response to treatment.